Rivastigmine Tartrate CAS 129101-54-8 Improved Brain Health

Product Description:

Product Name: Rivastigmine tartrate CAS NO: 129101-54-8

Synonyms:

N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate;

Rivastigmine;

(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate;

Chemical & Physical Properties:

Appearance: White to Off-White Powder

Assay :≥99.0%

Boiling Point: 316.2℃ at 760 mmHg

Melting Point: 123-125℃

Flash Point: 145℃

Vapor Pressure: 0.000416mmHg at 25℃

Storage temp.: 2-8℃

Solubility: H2O: soluble15mg/mL, clear

Safety Information:

Safety Statements: S24/25

HS Code: 2942000000

Hazard Code: Xi

Hazard Class: 6.1

Packing Group: III

Rivastigmine tartrate, an cholinesterase inhibitor(IC50= 5.5 uM), inhibits both butyrylcholinesterase and acetylcholinesteraseIC50 value: 5.5 uMTarget: AChERivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting. The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions. Rivastigmine, a cholinesterase inhibitor, inhibits both butyrylcholinesterase and acetylcholinesterase. It is thought to work by inhibiting these cholinesterase enzymes, which would otherwise break down the brain chemical acetylcholine.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.